Save Page settings
IBM Watson for Drug Discovery
Hero Array body Graece donan, Latine voluptatem vocant. Contineo me ab exemplis. Haec dicuntur inconstantissime.
Free 30-day trial
Transformational healthcare solutions from Truven Health Analytics®, now offered by IBM Watson Health.
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
TEST


Watson is helping Barrow Neurological Institute identify 5 new proteins linked to amyotrophic lateral sclerosis (ALS)


Watch the video
Resource Type

Watson is helping Barrow Neurological Institute identify 5 new proteins linked to amyotrophic lateral sclerosis (ALS)


Watch the video
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
Watch the video
Make scientific breakthroughs and increase your knowledge of disease - faster than ever before.
Watson for Drug Discovery (WDD) helps researchers identify novel drug targets and new indications for existing drugs (drug repurposing). The cloud-based platform can help researchers uncover new connections rapidly, which may lead to new insights and scientific breakthroughs. It is build off three core components; Knowledge, Cognitive and Visualization to help you answer your research questions.

Get the best answers to your research questions...

Read the research paper
Drug Target Identification
Using Artificial Intelligence and Advanced Natural Language Processing...
Watson for Drug Discovery can help you understand the disease and biological pathways to identify gene targets and compounds as potential drug candidates at a speed and scale beyond what is manually possible.

Barrow Neurological Institute applied cognitive computing with IBM’s Watson for Drug Discovery to identify 5 novel RNA binding proteins altered in ALS. From nearly 1,500 candidate proteins, Watson helped predict those most likely to be involved in the disease.
  • RAPID EXPLORATION: Within weeks, using predictive modeling, rank ordered ~1,500 RNA binding proteins for their association to ALS. Validated through retrospective analysis.
  • VALIDATED PREDICTIONS: Barrow examined Watson's top evidence-based predictions & found 8 of the top 10 ranked proteins were linked to the disease.
  • NEW DISCOVERY: Uncovered 5 never before linked proteins altered in patients with ALS.


CTA Label
Drug Repurposing
Vadem te ad mortem tyranno dabis pro amico
Let Watson for Drug Discovery answer your Questions...

CTA Label
Vast data sources
Watson for Drug Discovery brings together a large corpus of knowledge to draw its predicative power. These sources are updated every 3 weeks, so you always have the latest research at your fingertips.
CTA Label
Cognitive
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Visual analytics
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Title
Expand your research targets using the power of Artificial Intelligence
Watson for Drug Discovery ingests millions of pieces data from Medline abstracts, patents to PMC Open Access articles and processes them using the latest Natural language processing (NLP) and AI  technology to deliver predicative relationships for researchers to identify novel drug targets and new indications.
CTA Label
Drug Target Identification
Using Artificial Intelligence & advanced Natural Language Processing (NLP) Watson will help you understand the disease & biological pathways to identify new gene targets & compounds as potential drug candidates.

Case Study
Watson for Drug Discovery is helping researchers at Barrow Neurological Institute identify new drug targets for ALS research.
Watch Video Now
Drug Repurposing
Watson's cognitive computing capabailities will help you build on earlier research and scale Drug Repurposing to an industrial level. It can eliminate bias and detect hidden connections that may not be seen by researchers to predict potential relationships for further evaluation.

Case Study
Watson for Drug Discovery Equipped University of Toronto with Cognitive Tools to Accelerate Drug Repurposing for Parkinson’s Disease.
Watch Video Now
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Start your free trial today and ask your questions...

Start your free trial today and ask your key research questions...


Start your 30 Day Free Trial today and get the best answers to your key research questions with the power of AI...
  • What are a set of targets for a given disease area?
  • Which type of biological pathways should we consider?
  • What are some genes that may be regulated by gene X?
  • What other indications are there for this known target?
  • What other biological pathways does this drug/compound/target impact?

"We simply would not have and could not have accomplished the research we did without WDD. The approach itself would not have been feasible and the labor intensiveness would have been too great."

-Dr. Naomi Visanji,
Scientist, University Health Network


Simply fill out the form to get started with your free trial.


Event details title
calendar January 1, 2010
time 10:00 AM - 11:00 AM PST
person John Doe
"We simply would not have and could not have accomplish the research we did without WDD. The approach itself would not have been feasible and the labor intensiveness would have been too great."
-Dr. Naomi Visanji,
Scientist, University Health Network


"Watson now has uncovered five new proteins, RNA binding proteins that are changed in patients with ALS."
Dr. Robert Bowser, PhD
Professor and Chairman of Neuroscience, Barrow Neurological Institute
What are some genes that might be regulated by gene X?
John Doe,
ille Siculo fecit
What other indications are there for this known target?
John Doe,
ille Siculo fecit
What other biological pathways does this  drug/compound/target impact?
John Doe,
ille Siculo fecit
Transformational healthcare solutions from Truven Health Analytics®, now offered by IBM Watson Health.
APOLLO NOSCERE NOSMET
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos danda nescio
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
CTA Label
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos danda nescio
CTA Label
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.